SANDFORD D SMITH Insider Trading $AEGR Aegerion Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for SANDFORD D SMITH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SANDFORD D SMITH. SANDFORD D SMITH is Director in ARIAD PHARMACEUTICALS INC ($ARIA) and Director in QLT INC/BC ($QLTI) and Director in APRICUS BIOSCIENCES, INC. ($APRI) and Director in CYTOKINETICS INC ($CYTK) and Chief Executive Officer in Aegerion Pharmaceuticals, Inc. ($AEGR) and Director in Aegerion Pharmaceuticals, Inc. ($AEGR) and Director in Neuralstem, Inc. ($CUR) and Director in AKCEA THERAPEUTICS, INC. ($AKCA).
SANDFORD D SMITH in Aegerion Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SANDFORD D SMITH: Chief Executive Officer, Director
Holdings: 0 shares
Latest Transaction: Nov 30 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of SANDFORD D SMITH in Aegerion Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AEGR, AKCA, ARIA, CYTK, NVLN, SNCA, SEEL
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | D | 0.00 | 8,888 | 0 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | D | 18.26 | 40,000 | 730,400 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | D | 17.98 | 18,000 | 323,640 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | D | 32.55 | 5,012 | 163,141 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | D | 64.73 | 14,700 | 951,531 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | D | 15.00 | 8,569 | 128,535 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | D | 16.28 | 16,435 | 267,562 | 0 | |
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Sell | D | 0.00 | 2,890 | 0 | 0 | 2.9 K to 0 (-100.00 %) |
| Jul 29 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | M | 0.00 | 2,222 | 0 | 8,888 | |
| Jul 29 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Payment of Exercise | F | 1.55 | 777 | 1,204 | 2,890 | 3.7 K to 2.9 K (-21.19 %) |
| Jul 29 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Buy | M | 0.00 | 2,222 | 0 | 3,667 | 1.4 K to 3.7 K (+153.77 %) |
| Jan 29 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | M | 0.00 | 2,223 | 0 | 11,110 | |
| Jan 29 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Payment of Exercise | F | 6.78 | 778 | 5,275 | 1,445 | 2.2 K to 1.4 K (-35.00 %) |
| Jan 29 2016 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Buy | M | 0.00 | 2,223 | 0 | 2,223 | 0 to 2.2 K |
| Aug 25 2015 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Chief Executive Off ... | Option Exercise | A | 0.00 | 13,333 | 0 | 13,333 | |
| Aug 25 2015 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Chief Executive Off ... | Option Exercise | A | 18.26 | 40,000 | 730,400 | 40,000 | |
| Jun 29 2015 | AEGR | Aegerion Pharmaceu ... | SMITH SANDFORD D | Director | Option Exercise | A | 17.98 | 18,000 | 323,640 | 18,000 |
Page: 1